|
|
|
|
Kyverna Therapeutics Inc (NASDAQ: KYTX) |
|
|
|
| |
KYTX's Revenue Growth by Quarter and Year
Kyverna Therapeutics Inc 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| KYTX Revenue (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| 4th Quarter |
December |
-
|
0.00
|
0.00
|
0.00
|
| 3rd Quarter |
September |
-
|
0.00
|
0.00
|
0.00
|
| 2nd Quarter |
June |
-
|
0.00
|
0.00
|
0.00
|
| 1st Quarter |
March |
0.00
|
0.00
|
0.00
|
0.00
|
| FY |
|
0.00
|
0.00
|
0.00
|
0.00
|
| KYTX Revenue first quarter 2025 Y/Y Growth Comment |
Kyverna Therapeutics Inc in the first quarter 2025 recorded of $ 0.00 millions.
According to the results reported in the first quarter 2025, Kyverna Therapeutics Inc achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Kyverna Therapeutics Inc ' s Revenue no change of 0% ranks overall at the positon no. in the first quarter 2025.
|
| KYTX Revenue ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
- |
- |
- |
| 3rd Quarter |
September |
- |
- |
- |
- |
| 2nd Quarter |
June |
- |
- |
- |
- |
| 1st Quarter |
March |
- |
- |
- |
- |
| FY |
|
- |
- |
- |
- |
KYTX Revenue (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
- |
- |
- |
| 3rd Quarter |
September |
- |
- |
- |
- |
| 2nd Quarter |
June |
- |
- |
- |
- |
| 1st Quarter |
March |
- |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
- |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
| Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Kyverna Therapeutics Inc 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| KYTX's I. Quarter Q/Q Revenue Comment |
|
|
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| KYTX's I. Quarter Q/Q Revenue Comment |
|
|
|
Kyverna Therapeutics Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Mar 31 2025) |
12 Months Ending
(Dec 31 2024) |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
| Cumulative Revenue 12 Months Ending |
$ 0.00 |
$ 0.00 |
$ 0.00 |
$ 0.00 |
$ 0.00 |
| Y / Y Revenue Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Revenue Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential Revenue Change (TTM) |
- |
- |
- |
- |
- |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# |
# |
# |
# |
# |
| Cumulative Revenue growth Comment |
In the Mar 31 2025 period, Kyverna Therapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.
Kyverna Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. . |
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
|
| Cumulative Revenue growth
Comment |
In the Mar 31 2025 period, Kyverna Therapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.
Kyverna Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. . |
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
